Three separate medical studies have reported positive health outcomes for children, ranging from protective benefits of maternal vaccination to reduced psychiatric risks from ADHD treatment.

A three-year study published in Pediatrics examined newborns in Norway and found clear benefits for babies when mothers received COVID-19 vaccination during pregnancy. The research provides additional evidence supporting current recommendations for pregnant women to get vaccinated against COVID-19.

Separately, a large new study found that methylphenidate, the active ingredient in ADHD medications such as Ritalin and Concerta, may lower the risk of psychosis when prescribed to younger children with attention deficit hyperactivity disorder. The stimulant medication showed potential protective effects against later development of psychotic symptoms.

Meanwhile, medical professionals have expressed concerns about increased FDA scrutiny of RSV antibody shots designed to protect infants. The antibody treatments demonstrate approximately 80% effectiveness at preventing babies from requiring intensive care due to respiratory syncytial virus infections. Pharmaceutical companies manufacturing these treatments maintain they are safe for infant use.

The studies contribute to growing research on pediatric health interventions and maternal medicine, providing data that may influence clinical guidelines and treatment recommendations for healthcare providers treating children and pregnant women.